Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Baricitinib in Alzheimer Disease: NCT05189106 Clinical Landscape Report 2026
16 October 2026
NCT05189106 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Anemia: CTRI/2022/01/039317 Clinical Landscape Report 2026
16 October 2026
CTRI/2022/01/039317 clinical landscape for Anemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pirfenidone in Idiopathic Pulmonary Fibrosis: NCT05195918 Clinical Landscape Report 2026
16 October 2026
NCT05195918 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dolutegravir Sodium in Amyotrophic Lateral Sclerosis: NCT05193994 Clinical Landscape Report 2026
16 October 2026
NCT05193994 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Chiglitazar Sodium in Metabolic Dysfunction Associated Steatohepatitis: NCT05193916 Clinical Landscape Report 2026
16 October 2026
NCT05193916 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT05195944 Clinical Landscape Report 2026
16 October 2026
NCT05195944 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hepatitis B vaccine(GlaxoSmithKline Plc) in Hepatitis B: NCT05200338 Clinical Landscape Report 2026
16 October 2026
NCT05200338 clinical landscape for Hepatitis B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Hemolysis: NCT05199766 Clinical Landscape Report 2026
16 October 2026
NCT05199766 clinical landscape for Hemolysis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dalnacogene ponparvovec in Hemophilia B: NCT05203679 Clinical Landscape Report 2026
16 October 2026
NCT05203679 clinical landscape for Hemophilia B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Etavopivat in Anemia, Sickle Cell: LBCTR2021124934 Clinical Landscape Report 2026
16 October 2026
LBCTR2021124934 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fasudil Hydrochloride Hydrate in Amyotrophic Lateral Sclerosis: NCT05218668 Clinical Landscape Report 2026
16 October 2026
NCT05218668 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VK-2735 in Metabolic Dysfunction Associated Steatohepatitis: NCT05203237 Clinical Landscape Report 2026
16 October 2026
NCT05203237 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…